A point-of-care testing platform leveraging gold nanoparticle technology with novel antifouling surface chemistry for rapid, multiplex detection of DNA and RNA, including GMO identification, in plant samples. Two complementary approaches—electrochemical and paper-based sensing—are being developed and compared to deliver a miniaturized, field-ready tool for non-expert users, with results available within two hours.
This research program is developing a point-of-care testing (POCT) platform for multiplex DNA and RNA detection in plant materials, with a particular focus on identifying genetically modified organisms (GMOs). The platform is built on gold nanoparticle (GNP) technology and is being pursued through two parallel approaches: an electrochemical biosensor using screen-printed electrodes and a paper-based biosensor using thin-layer chromatography. Both formats are designed to be miniaturized, user-friendly, and operable in field settings by non-expert staff, addressing the need for rapid genetic quality assessment outside of laboratory environments. The program is led from Prof. Michael Thompson's lab at the University of Toronto, with collaboration across surface chemistry, electrochemistry, and biosensing expertise.
Core technology components:
The project is at an early-to-mid stage of development, supported by substantial preliminary evidence. Prior work has demonstrated selective electrochemical detection of CTV nucleic acids in plant samples, differentiation of GMO soybeans without complex cleaning procedures, and significant reduction of non-specific adsorption using the novel dithiol linker on gold surfaces validated through electrochemical and acoustic wave platforms. A clinical diagnostics electrochemical biosensor incorporating this linker has also shown reduced fouling and enhanced sensitivity. The feasibility of the proposed POCT concept is further supported by commercial precedents such as glucose meters (electrochemical) and COVID-19 rapid tests (paper-based). The upcoming year-long validation phase will optimize GNP modification with dithiol linkers, fabricate and test both biosensor formats, and compare their performance for simultaneous DNA/RNA detection in plant materials.
The University of Toronto is a comprehensive public research university with three campuses in the Toronto region and a globally scaled research enterprise. Its downtown footprint is embedded within a major academic health network and an adjacent innovation district, enabling co-located labs, clinical trials, and rapid testing with end users. Companies connect through co-op and long-duration internships, sponsored research, and access to shared core facilities and prototyping resources. Research is supported by Canada’s Tri‑Agency (NSERC, CIHR, SSHRC) and the Canada Foundation for Innovation, alongside provincial programs and industry partnerships. A dedicated technology transfer office provides IP management, licensing, and startup support through a coordinated entrepreneurship network.